Home
>
National Drug Code (NDC)
>
Parcopa
Parcopa - 18860-343-01 - (Carbidopa and Levodopa)
Drug Information of Parcopa
| Product NDC: | 18860-343 |
| Proprietary Name: | Parcopa |
| Non Proprietary Name: | Carbidopa and Levodopa |
| Active Ingredient(s): | 25; 250 mg/1; mg/1 & nbsp; Carbidopa and Levodopa |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Parcopa
| Product NDC: | 18860-343 |
| Labeler Name: | Jazz Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076699 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040901 |
Package Information of Parcopa
| Package NDC: | 18860-343-01 |
| Package Description: | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (18860-343-01) |
NDC Information of Parcopa
| NDC Code | 18860-343-01 |
| Proprietary Name | Parcopa |
| Package Description | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (18860-343-01) |
| Product NDC | 18860-343 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Carbidopa and Levodopa |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20040901 |
| Marketing Category Name | ANDA |
| Labeler Name | Jazz Pharmaceuticals, Inc. |
| Substance Name | CARBIDOPA; LEVODOPA |
| Strength Number | 25; 250 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA] |
